Clinical evaluation of pyrantel pamoate in helminthiasis.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000871:Anthelmintics / Q000008:administration & dosage* / Q000009:adverse effects; D001196:Ascariasis / Q000188:drug therapy; D002264:Carboxylic Acids / Q000008:administration & dosage / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D005243:Feces; D006725:Hookworm Infections / Q000188:drug therapy; D006801:Humans; D007223:Infant; D008875:Middle Aged; D009281:Naphthalenes / Q000008:administration & dosage / Q000009:adverse effects; D009331:Necator; D009349:Nematode Infections / Q000188:drug therapy*; D010270:Parasite Egg Count; D011743:Pyrimidines / Q000008:administration & dosage* / Q000009:adverse effects; D013607:Tablets; D013876:Thiophenes / Q000008:administration & dosage / Q000009:adverse effects; D014259:Trichuroidea
D000871:Anthelmintics; D002264:Carboxylic Acids; D009281:Naphthalenes; D011743:Pyrimidines; D013607:Tablets; D013876:Thiophenes